{
    "clinical_study": {
        "@rank": "129353", 
        "acronym": "WS-RT Fibro", 
        "arm_group": {
            "arm_group_label": "Initial monitoring group", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "It's a monitoring study. The aim is to assess the progression free survival up to 3 years.\n      Patients are not treated until progression. Search for scalability predictive factors and\n      registration of treatments if progression."
        }, 
        "brief_title": "Peripheral Primitive Fibromatosis", 
        "completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Peripheral Primitive Fibromatosis", 
        "condition_browse": {
            "mesh_term": "Fibroma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Peripheral primitive fibromatosis\n\n          -  Adults patients\n\n          -  Peripheral primitive fibromatosis proved by biopsy\n\n          -  Peripheral primitive fibromatosis R2 resected for which monitoring is decided\n\n          -  MRI realized before inclusion\n\n          -  Patient information and informed consent signed\n\n        Exclusion Criteria:\n\n          -  Local recur\n\n          -  Head and neck topography\n\n          -  Primitive fibromatosis R0 or R1 resected\n\n          -  Specific medical treatment of fibromatosis\n\n          -  Patient already included in an other clinical trial with an experimental molecule\n\n          -  Persons deprived of liberty\n\n          -  Impossibility to submit to the trial's medical follow-up for psychological,\n             geographical or socials reasons\n\n          -  Previous history of cancer\n\n          -  Counter indication to the realization of an MRI"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01801176", 
            "org_study_id": "2011-A01188-33", 
            "secondary_id": "2011/1774"
        }, 
        "intervention": {
            "arm_group_label": "Initial monitoring group", 
            "description": "MRI every 3 months during the first year and then every 6 months during the second year and then one MRI up to 36 months", 
            "intervention_name": "MRI", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "proved by biopsy", 
        "lastchanged_date": "February 27, 2013", 
        "location": {
            "contact": {
                "email": "bonvalot@igr.fr", 
                "last_name": "Sylvie BONVALOT, MD", 
                "phone": "0142114383", 
                "phone_ext": "+33"
            }, 
            "contact_backup": {
                "email": "thibaud.motreff@igr.fr", 
                "last_name": "Thibaud MOTREFF", 
                "phone": "0142116643", 
                "phone_ext": "+33"
            }, 
            "facility": {
                "address": {
                    "city": "Villejuif", 
                    "country": "France", 
                    "state": "Val de Marne", 
                    "zip": "94805"
                }, 
                "name": "Institut Gustave Roussy"
            }, 
            "investigator": {
                "last_name": "Sylvie BONVALOT, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Peripheral Primitive Fibromatosis. Study Evaluating a Simple Initial Monitoring With Search of Scalability Predictive Factors and Registration of Treatments in Case of Progression", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Progression Free Survival", 
            "safety_issue": "No", 
            "time_frame": "assessed up to 3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01801176"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Assessed  with criteria for Adverse Effects-V4 scale once per year during the consultation", 
            "measure": "Functional result", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Gustave Roussy, Cancer Campus, Grand Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gustave Roussy, Cancer Campus, Grand Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "February 2012"
    }
}